SUVRETTA CAPITAL MANAGEMENT, LLC bought BNTC

December 22, 2025 · Form 4 insider transaction

SUVRETTA CAPITAL MANAGEMENT, LLC bought 2,892 shares of BENITEC BIOPHARMA INC at $12.08 per share, a transaction worth $34.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction

Acquired (buy-side)

2,892

Price

$12.08

Total value

$34.9K

InsiderSUVRETTA CAPITAL MANAGEMENT, LLC

RoleDirector, 10% owner

CompanyBENITEC BIOPHARMA INC (BNTC)

SecurityCommon stock, par value $0.0001 per share

Transaction codeP — Open-market purchase

Transaction dateDecember 22, 2025

Filing dateDecember 22, 2025

Shares owned after1,826,653

OwnershipIndirect

10b5-1 planNo

AmendedNo

Footnotes

Notes are included on Exhibit 99.1.; Notes are included on Exhibit 99.1.

View the original Form 4 on SEC EDGAR